Notably, OE-APT1-AAV transduction markedly ameliorated diabetes-induced podocyte injury and glomerular damage, including mesangial proliferation and sclerosis, narrowing of peripheral capillary loops, foot process effacement, and glomerular basement membrane thickening (Figure 7J-L). This evidence concerns the gene LYPLA1 and diabetes mellitus.